
Journal of Medicinal Chemistry p. 2343 - 2349 (1993)
Update date:2022-08-05
Topics:
Kubo
Kohara
Yoshimura
Inada
Shibouta
Furukawa
Kato
Nishikawa
Naka
In order to improve the oral bioavailability (BA) of 2-butyl-1-[[2'-(1H- tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid (3: CV-11194) and 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H- benzimidazole-7-carboxylic acid (
View MoreShenzhen Sunrising Industry Co., ltd.
Contact:+86 755 86571158 / 86571159 / 86571160
Address:2108 ZHENYE INT. BUSINESS CENTER,NO.3101-90 QIANHAI RD, NANSHAN,SHENZHEN, CHINA
Contact:86-791-86629460
Address:1-6F, 118 Xinzhou road, Nanchang, Jiangxi, China
website:http://www.ringchemicals.com/
Contact:+1-416-493-6870
Address:Toronto, Canada
website:http://www.alwaychem.com
Contact:+86-532-8586-4000, 8586-5000
Address:NO.51, TAIPING ROAD, QINGDAO, CHINA. 266001
Guangzhou Probig Fine Chemical Co., Ltd.
Contact:020-86297874
Address:No.2, 1/F, No.20, Hetai Road,Hebian Village, Baiyun District,Guangzhou,China
Doi:10.1002/hlca.19490320319
(1949)Doi:10.1021/jm00373a008
(1984)Doi:10.3390/antibiotics10040369
(2021)Doi:10.1016/j.bmc.2018.02.022
(2018)Doi:10.1039/b601804a
(2006)Doi:10.1021/jm060011o
(2006)